Lupin completes major expansion of U.S. manufacturing facility by Eric Palmer Thursday, May 11, 2017 A U.S. generics manufacturing site that India’s Lupin picked up in its 2015 buyout of GAVIS Pharmaceuticals has now been significantly expanded as the drugmaker continues to make a push into the U.S. market.
